NUVECTIS PHARMA INC
NVCT · NASDAQ
Updated at 2026-10-14 08:52:42
- Today's High
- $19.87
- Today’s Low
- $18.01
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $21.12
- Previous Close
- $19.69
- Volume
- 145.82K
- Market Cap
- $642.76M
- P/E Ratio
- --
- EPS
- $-1.20
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1 BRIDGE PLAZA, FORT LEE, NJ, UNITED STATES, 07024
- Country
- US
- Listing Date
- 2022-02-04
- Fiscal Year End
- December
- Shares Outstanding
- 31.53M
- CIK
- 0001875558
- Website
- nuvectis.com
Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer. The company is headquartered in Fort Lee, New Jersey.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$7.19M
2026-03-31
$6.26M
2025-12-31
$7.61M
2025-09-30
$7.79M
Net Income
2026-06-30
-$7.02M
2026-03-31
-$6.05M
2025-12-31
-$7.31M
2025-09-30
-$7.46M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.30
2026-03-31
$-0.26
2025-12-31
$-0.31
2025-09-30
$-0.44
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$7.19M
2026-03-31
-$6.05M
2025-12-31
-$8.21M
2025-09-30
-$7.46M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $7.19M | $6.26M | $7.61M | $7.79M |
| Net Income | -$7.02M | -$6.05M | -$7.31M | -$7.46M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.30 | $-0.26 | $-0.31 | $-0.44 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$7.19M | -$6.05M | -$8.21M | -$7.46M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.